Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This Phase 2 protocol is designed to compare two dose levels of laninamivir octanoate versus placebo. The objectives are to obtain safety and efficacy in adults aged 18 to 64 years who present to clinic with symptomatic presumptive influenza A or B infection.
Epistemonikos ID: cd038cf4e3377b203d01cc4b93b622e48c3e7fe0
First added on: Mar 23, 2020